drugset / Trial / NCT00151008
Bexarotene With Narrow-Band UVB for Psoriasis
Phase 2
Completed
35 enrolled
University of Medicine and Dentistry of New Jersey
Ligand Pharmaceuticals · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To determine if bexarotene gel with NBUVB phototherapy is more effective than placebo plus NBUVB for moderate to severe plaque-type psoriasis.
Timeline
- Start
- 2003-11
- Primary completion
- —
- Completion
- 2005-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bexarotene | Small molecule | 1 % | Topical |